Lataa...
Role of oral teriflunomide in the management of multiple sclerosis
The landscape of the treatment of relapsing–remitting multiple sclerosis is changing fast. Several oral treatments have shown benefit and generate much interest because of the convenience of their administration. Two oral compounds, fingolimod and teriflunomide, have been approved in relapsing–remit...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3639219/ https://ncbi.nlm.nih.gov/pubmed/23637535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S31248 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|